US FDA approves expanded use of Sanofi’s type 1 diabetes drug in children aged 8 to 17
However, the drug, Tzield, has also been under FDA scrutiny over safety concerns.
Original Source
Read the full article at Straitstimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.